Covidien plc (NYSE:COV) will take its Solitaire FR revascularization device directly to regulators rather than wait for additional clinical data, after an independent panel’s review of the data collected so far.
Xoft Inc. could turn out to be a lot more expensive for iCad (NSDQ:ICAD) than the $1 million in cash and the 8.47 million shares of stock it paid for the oncology device manufacturer late last year.
Fresenius Medical Care AG (NYSE:FMS) shares are rebounding from earlier losses and were back to within 50 cents of even for today’s session at $68.14 each, after the German medical device manufacturer announced plans to acquire the Crit-Line system from privately held Hema Metrics. Terms of the deal were not immediately available.
Boston Scientific Corp. (NYSE:BSX) co-founder John Abele will not stand for re-election to the company’s board when his current term expires in May. Two other long-time board members — Marye Anne Fox and Ray Groves — also plan to step down.
Buoyed by strong growth in the vision-care unit during its latest reporting period, The Cooper Companies Inc. (NYSE:COO) last night raised its earnings and revenue forecast for the rest of the year, sending the company’s stock on a tear when trading began this morning.
Executives at NeuroMetrix Inc. (NSDQ:NURO) don’t appear to be in any rush to take on any new debt, but they could borrow up to $7.5 million after signing a one-year extension of a revolving credit facility with Comerica Bank.
Boston Scientific (NYSE:BSX) is getting a big boost this morning, climbing as much as 6 percent in early trading after RBC Capital Markets reportedly raised its rating for the medical device maker’s stock.
BSX shares touched $7.62 apiece early today, before backing down to its current range of about $7.50 per share. The stock last traded this high just one week ago, before sliding nearly 7 percent between Tuesday and Thursday’s close.
Varian Medical Systems Inc. (NYSE:VAR) late last week inked a deal with Bank of America to buy back about $280 million worth of its common stock, reducing the amount of outstanding shares by almost 3 percent.
Medtronic Inc.’s (NYSE:MDT) move last week to cancel $2 billion worth of supply contracts with Novation LLC could save the device maker some $60 million a year. It’s a no-brainer for one of med-tech’s biggest players, but it might signal a wider trend: Will the medical device industry buck group purchasing organizations even as hospitals flock to them?
St. Jude Medical Inc. (NYSE:STJ) shares are slightly lower today, falling 26 cents to $47.75 after the medical device maker disclosed plans to begin paying a quarterly dividend to shareholders.
The move has the St. Paul, Minn.-based medical device maker joining a gaggle of healthcare firms to initiate or expand payments in recent weeks.